1. Home
  2. PODD vs CPAY Comparison

PODD vs CPAY Comparison

Compare PODD & CPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • CPAY
  • Stock Information
  • Founded
  • PODD 2000
  • CPAY 1986
  • Country
  • PODD United States
  • CPAY United States
  • Employees
  • PODD N/A
  • CPAY N/A
  • Industry
  • PODD Medical/Dental Instruments
  • CPAY EDP Services
  • Sector
  • PODD Health Care
  • CPAY Technology
  • Exchange
  • PODD Nasdaq
  • CPAY Nasdaq
  • Market Cap
  • PODD 21.5B
  • CPAY 24.6B
  • IPO Year
  • PODD 2007
  • CPAY 2010
  • Fundamental
  • Price
  • PODD $292.01
  • CPAY $326.24
  • Analyst Decision
  • PODD Strong Buy
  • CPAY Buy
  • Analyst Count
  • PODD 19
  • CPAY 14
  • Target Price
  • PODD $320.11
  • CPAY $397.17
  • AVG Volume (30 Days)
  • PODD 753.8K
  • CPAY 469.1K
  • Earning Date
  • PODD 08-07-2025
  • CPAY 08-06-2025
  • Dividend Yield
  • PODD N/A
  • CPAY N/A
  • EPS Growth
  • PODD 67.46
  • CPAY 6.08
  • EPS
  • PODD 5.55
  • CPAY 14.26
  • Revenue
  • PODD $2,198,900,000.00
  • CPAY $4,045,005,000.00
  • Revenue This Year
  • PODD $24.49
  • CPAY $13.37
  • Revenue Next Year
  • PODD $17.45
  • CPAY $10.56
  • P/E Ratio
  • PODD $52.60
  • CPAY $22.94
  • Revenue Growth
  • PODD 23.48
  • CPAY 6.68
  • 52 Week Low
  • PODD $173.00
  • CPAY $265.06
  • 52 Week High
  • PODD $329.33
  • CPAY $400.81
  • Technical
  • Relative Strength Index (RSI)
  • PODD 38.75
  • CPAY 46.17
  • Support Level
  • PODD $289.03
  • CPAY $328.12
  • Resistance Level
  • PODD $300.00
  • CPAY $337.15
  • Average True Range (ATR)
  • PODD 7.17
  • CPAY 7.84
  • MACD
  • PODD -1.98
  • CPAY -0.40
  • Stochastic Oscillator
  • PODD 11.05
  • CPAY 25.43

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About CPAY Corpay Inc.

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.

Share on Social Networks: